Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remazolam vs Propofol for Sedation in Non-intubated Thoracoscopic Lung Surgery
NCT06810843Not yet recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of remimazolam mesylate (2 arms), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoint: Incidence of hypoxia. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
remimazolam mesylate
Beyond the preview
Go deeper on NCT06810843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06810843.